Skip to main content
. 2016 Apr 26;2016(4):CD011996. doi: 10.1002/14651858.CD011996.pub2

1.3. Analysis.

1.3

Comparison 1 Intranasal corticosteroids versus placebo, Outcome 3 Disease severity ‐ combination of individual symptom scores, measured on a 0 to 3 scale as change from baseline at 12 to 20 weeks.